- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Diagnostic Imaging's A Look Ahead: Dec. 14, 2020, to Dec. 20, 2020
Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
In continuing end-of-year coverage, keep an eye out for a look back at CT throughout 2020. What were the biggest developments and changes during the year. The biggest focus over the past nine months has certainly been with COVID-19, but what else happened with the modality as the pandemic raged?
For additional end-of-year coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
RadXX announced their four award winners during RSNA – Trailblazer, Advocate, Rising Star, and Champion. Diagnostic Imaging spoke with each winner to find out not only what launched their interest in medical imaging informatics, but also what their visions were for the specialty going forward. Later this week, you can access a short video where they share their thoughts in their own words.
For more of the RadXX profiles, click here.
In the past 40 years, liver cancer diagnoses have tripled, and deaths have nearly doubled, making it a cancer to watch closely. Later this week, look for coverage of research that focuses on the use of ultrasound to impact liver tumors, potentially affecting overall treatment outcomes.
For additional liver cancer coverage, click here.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.
